CNHHE

CMP News

Once a chemical is found to pose a risk, scientists and policy people with the Chemicals Management Plan design a strategy to manage the chemical and the risk it poses. They might decide that it is important to phase out the use or production of the substance because it is too dangerous. They might propose regulations to limit or make the use of a chemical safer.

At every step along the way there are Public Comment Periods open to the people of Canada to comment on a draft document about a chemical. These comments, and the CMP Science Committee and Stakeholder Advisory Council help the government make decisions about how to manage a chemical or group of chemicals for the safety of Canadians and our environment. 

 Latest from the CMP

Information from Health Canada Regarding the Consumer Prod ucts Containing Lead Regulations

Are the consumer  products you manufacture, import, advertise or sell in Canada subject to the requirements under the Consumer Products Containing Lead Regulations?

The Regulations were amended in 2018 to expand their scope to include:

  • products intended for use in learning or play (toys) by children under 14 years of age;
  • clothing or clothing accessories intended for use by a child under 14 years of age; and
  • products whose primary purpose is to facilitate the relaxation, sleep, hygiene, carrying or transportation of a child under 4 years of age.

Health Canada has published Information for Regulated Parties Regarding the Consumer Products Containing Lead Regulations to provide more details on:

  • examples of products in scope of the Regulations,
  • exceptions, and
  • test methods.


You can consult the document at the following links:

https://www.canada.ca/en/health-canada/services/consumer-product-safety/legislation-guidelines/guidelines-policies/consumer-products-lead-regulations.html

Webinar: Applying Economic Insight to Environmental Health Risk Management March 30th, 2022 1pm AST 12pm EST

The webinar is being presented by Wambui Kipusi, Healthy Environments and Consumer Safety Branch, Health Canada. She previously did economic analysis linked to climate change, air pollution and toxic chemicals at Environment and Climate Change Canada. She did her graduate studies in economics, business and policy at Dalhousie University.

 

The webinar will examine how Governments often take policy actions intended to reduce human health risks from environmental contaminants deemed to adversely affect the wellbeing of Canadians. Assessing the impacts of these actions, and determining whether they are beneficial, can be complex and time-consuming.  In order to inform decision-making and subsequent policy choices, governments draw on expertise from many disciplines including science, engineering and economics.  This presentation will provide:

  • An overview of how economics informs environmental health risk management actions
  • Application examples

Fluorescent brightener 367

The Final Screening Assessment for Benzoxazole, 2,2′-(1,4-naphthalenediyl)bis- was publishedThis substance was identified for action under the Chemicals Management Plan (CMP).
The screening assessment focused on benzoxazole, 2,2′-(1,4-naphthalenediyl)bis-, also referred to as fluorescent brightener 367, which was assessed under the third phase of the Chemicals Management Plan (CMP). Fluorescent brightener 367 does not occur naturally in the environment. According to information gathered by the Government, it was not manufactured or imported into Canada above the reporting thresholds. Fluorescent brightener 367 may be found in cosmetics, such as certain nail polishes.

The Draft Screening Assessment for Select Hydrocarbon-based Substances was published for a 60-day public comment period ending on March 9, 2022.

The screening assessment summarized here focuses on 8 hydrocarbon-based substances, assessed under the Chemicals Management Plan (CMP). The substances addressed are petroleum resins, hydrocarbon resin, polymerized C5-12 distillates, oxidized hydrocarbon waxes with ethanolamine, oxidized hydrocarbon waxes with 2-(methylamino)ethanol, alkylated naphthalene sulfonate sodium salt polymers with formaldehyde, heavy oxo ends, and sulfurized petroleum. To learn more about The Draft Screening Assessment for Select Hydrocarbon-based Substances was published for a 60-day public comment period ending on March 9, 2022, click here.

To inquire about honorarium to support the CMP mandate, please contact Andrew Holloway M.Sc at the New Brunswick Lung Association via email at andrew.holloway@nb.lung.ca

Updated Pre-Budget Consultation

Updated pre-budget consultation

Feb 25, 2022

RESILIENT has submitted a pre-budget consultation brief to the Federal Department of Finance with our recommendations for Canada to emerge from the COVID-19 pandemic healthier and more resilient.

“Human Health, the economy, and our environment are inextricably linked”

This process echoes submissions to the Federal Finance Committee made in August 2021. Our recommendations continue to centre on:

  • Taking strong action on climate change by diverting fossil fuel subsidies into the green economy and a just transition for the fossil fuel workforce, and accelerating the adoption of low carbon commuting
  • Preventing climate change mitigation from increasing air pollution by including radon mitigation in energy efficiency rebates and mandating a reduction in wood smoke pollution
  • Launching a national pharmacare system
  • Modernizing the Canadian Environmental Protection Act (CEPA) in line with current science
  • Implementing a recovery basic income

We are encouraged that Bill C-28 (and Act to Modernize CEPA) that was introduced in April 2021 we re-instated in the Senate as Bill S-5 in the current session of Parliament. We urge that modernization to CEPA go forward without delay.

To read our full written submission for the pre-budget consultations click here

To read 2021 written submission for the pre-budget consultations click here

Sixth Report on Human Biomonitoring of Environmental Chemicals in Canada

Sixth Report on Human Biomonitoring of Environmental Chemicals in Canada: Results of the Canadian Health Measures Survey Cycle 6 (2018-2019), along with 8 biomonitoring fact sheets for a selection of chemicals. 

A technical briefing was held this morning presenting highlights from the report and fact sheets. A PDF copy of the presentation is attached.

The Canadian Health Measures Survey (CHMS) is a comprehensive direct health measures survey conducted by Statistics Canada, in partnership with Health Canada and the Public Health Agency of Canada. The CHMS includes a biomonitoring component, funded by Health Canada, which measures the levels of environmental chemicals in individual samples of blood and urine. Health Canada’s National Biomonitoring Program reports are key deliverables under the Chemicals Management Plan.

The Sixth Report contains summary data for 79 environmental chemicals measured in cycle 6 of the CHMS. It features data for the same set of chemicals presented in the previous Fifth Report, except for volatile organic compounds (VOCs), which were excluded for cycle 6. The report does not address any health outcomes, provide analyses or conclusions, or recommend policy direction. It is strictly a technical document that outlines objectives, describes the survey design and methods, and provides descriptive summaries of measured environmental chemicals, along with approximately 130 data tables.

New this year is the publication of biomonitoring fact sheets that highlight changes in chemical exposures over time, distributions across age groups, differences between males and females, and comparisons between the Canadian population and other populations in Canada and the United States. Eight fact sheets have been released this year on arsenic, cadmium, lead, mercury, PFAS, DEHP, bisphenol A (BPA) and parabens.

Data files are also available through Statistics Canada’s Research Data Centers (RDCs).

Methylstyrenated phenol

Draft Screening Assessment

Risk Management
The draft screening assessment for methylstyrenated phenol has been published. It is proposed to conclude that the substance may be harmful to the environment and meets the criteria under paragraph 64(a) of the Canadian Environmental Protection Act, 1999 (CEPA). A risk management scope has been published concurrently to initiate discussions with stakeholders on the risk management options being considered.

Flame Retardants Group

Draft Screening Assessment

Risk Management Scope
The draft screening assessment for the Flame Retardants group has been published. It is proposed to conclude that IPPP may be harmful to the environment and to human health and meets the criteria under paragraphs 64(a) and (c) of CEPA. It is also proposed to conclude that TPHP, BPDP, BDMEPPP and IDDP may be harmful to the environment and meet the criteria under paragraph 64(a) of CEPA, while TEP may be harmful to human health and meets the criteria under paragraph 64(c) of CEPA.   A risk management scope has been published concurrently to initiate discussions with stakeholders on the risk management options being considered.   It is also proposed to conclude that the remaining six substances do not meet any of the criteria set out in section 64 of CEPA.

Approach for a Subset of Organic and Inorganic Substances Prioritized Under the Chemicals Management Plan

Science Approach
Document Webpage
This approach addresses 9 organic and inorganic substances that were identified as priorities for assessment as they met the categorization criteria under subsection 73(1) of the Canadian Environmental Protection Act, 1999 (CEPA) or were considered a priority based on other human health concerns.   It is proposed that these substances not undergo further assessment at this time.

Priority B (medium hazard) micro-organisms on the Domestic Substances List

Priority B (medium hazard) micro-organism strains on the Domestic Substances List (DSL) were given a medium priority for assessment because while they are not specifically identified as pathogens, the Government of Canada identified evidence in the scientific literature that indicates they may have the potential to cause harm to human health or the environment. More information about the prioritization of micro-organisms on the Domestic Substances List is available. Information on all micro-organism assessments is also available. More information here

Canada’s Chemicals Management Plan (CMP)

Canada’s Chemicals Management Plan (CMP) program is sharing the following Publications Plan to inform stakeholders of publications from October to December 2021. Please note that the targeted publication dates are subject to change. The program anticipates sharing the Publications Plan for January to March 2022 by winter 2021.

Environment and Climate Change Canada and Health Canada recognize the impacts faced by Canadians in light of current events and understand the importance of stakeholder engagement. If you anticipate any challenges with providing your comments within the 60-day public comment period, if applicable, please inform the program at the earliest opportunity.

Publications targeted for October to December
Acids & Bases DSAR a
Approach for a Subset of Organic and Inorganic Substances Prioritized under the Chemicals Management Plan b
Flame Retardants DSAR a
Phenol, methylstyrenated DSAR a

a Draft Screening Assessment Reports (DSAR) presenting information on health and ecological considerations and, where criteria under s. 64 are proposed to be met, Risk Management Scope documents.

b Science-based policy approach document.  

Note: Group names are not final and may change

To inquire about honorarium to support the CMP mandate, please contact Andrew Holloway M.Sc at the New Brunswick Lung Association via email at andrew.holloway@nb.lung.ca

Webinar Registration – Sep 29, 2021 02:00 PM

Topic: Per- and Polyfluorinated Alkyl Substances (PFAS): A Review “From PFOS to GenX”DescriptionCNHHE is pleased to present Terry Obal, PhD, CChem, Chief Science Advisor, Bureau Veritas Laboratories to discuss the state of the science around PFAS chemicals.

Perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA) and related per- and polyfluorinated alkyl substances (PFAS) are recognized by environmental practitioners and regulatory bodies around the world as compounds of environmental concern. These persistent chemicals are found widely in the environment. The ubiquity of these compounds in a wide range of environmental and biological matrices, compounded with their chemical properties and studies suggesting human toxicity have resulted in increased public concern.

In April 2021, the Government of Canada published a notice of intent in the Canada Gazette considering activities that would address the broad class of PFAS.

This presentation will provide a brief overview of the science around PFAS including:

• PFAS as contaminants of emerging environmental concern
• Exposure and toxicity
• Sampling and analysis considerations – Soil, water, tissue and air
• Treatment and remediation – What are our options?
• The future of PFAS in the environmental marketplace

Lotus corniculatus, extract

The final screening assessment for Lotus corniculatus, extract has been published. It is concluded that the substance does not meet any of the criteria set out in section 64 of CEPA. The Final Screening Assessment is HERE & The Canada Gazette Notice is HERE

Comments or information submitted with respect to the above publication must cite the Canada Gazette, Part I, along with the date of publication of the notice, and can be provided to the Minister of the Environment until October 13, 2021, using one of the following methods:

  • Online through Environment and Climate Change Canada’s Single Window,
  • By email to substances@ec.gc.ca, with the name of the publication in the subject line. If you wish to comment on multiple publications, please submit your comments in separate emails; or
  • By mail to the Executive Director, Program Development and Engagement Division, Environment and Climate Change Canada, 351 St-Joseph Blvd., 6th floor, Gatineau (QC) K1A 0H3.

Caprolactam

The draft screening assessment for caprolactam has been published. It is proposed to conclude that the substance does not meet any of the criteria set out in section 64 of the Canadian Environmental Protection Act, 1999 (CEPA). The Draft Screening Assessment is found HERE and the Canada Gazette Notice can be located HERE

Comments or information submitted with respect to the above publication must cite the Canada Gazette, Part I, along with the date of publication of the notice, and can be provided to the Minister of the Environment until October 13, 2021, using one of the following methods:

  • Online through Environment and Climate Change Canada’s Single Window,
  • By email to substances@ec.gc.ca, with the name of the publication in the subject line. If you wish to comment on multiple publications, please submit your comments in separate emails; or
  • By mail to the Executive Director, Program Development and Engagement Division, Environment and Climate Change Canada, 351 St-Joseph Blvd., 6th floor, Gatineau (QC) K1A 0H3.

Anthraquinones Group

The Final Screening Assessment for the Anthraquinones Group was published. The Proposed Risk Management Approach for Solvent Violet 13 was also published for a 60-day public comment period ending on September 15, 2021. Available here.

Mitotane

An order amending the Domestic Substances List to apply the Significant New Activity (SNAc) provisions of the Canadian Environmental Protection Act, 1999 to Mitotane was published. Available here.

Lead

The proposed Regulations for Prohibiting the Manufacture and Import of Wheel Weights Containing Lead in Canada were published for a 70 public comment period ending September 11, 2021. Available here.

Formaldehyde

The final Formaldehyde Emissions from Composite Wood Products Regulations and the final Directive Concerning Testing for Formaldehyde Emissions were published. Available here.

Zinc

The Additional Risk Characterization Document in Support of the Draft Screening Assessment for Zinc and its Compounds: Pulp and paper sector exposure and risk characterization was published. Available here.

Fact Sheets

Two new fact sheets were published: 1. Use of margins of exposure and risk quotients in risk assessment, and 2. Canadian exposure factors used in human health risk assessments. Available here.

Coal Tars

The Final Screening Assessment for Coal Tars and their Distillates was published. The Risk Management Approach for Coal Tars and their Distillates and the proposed order adding coal tars to Schedule 1 of the Canadian Environmental Protection Act, 1999 were also published for a 60-day public comment period ending on August 25, 2021. Available here.

DEHP

The performace measurement evaluation for DEHP was published. Available here.

Priority A (higher hazard) micro-organism

A notice of intent to amend the Domestic Substances List to vary the requirements under the Significant New Activity (SNAc) provisions of the Canadian Environmental Protection Act, 1999 for Pseufomonas fluorescens ATCC 13525 was published for a 60-day public comment period ending on August 18, 2021. A notice of intent to amend the Domestic Substances List to rescind the requirements under the SNAc provisions for Pseudomonas aeruginosa strains ATCC 31480, 700370 and 700371 was also published for a 60-day public comment period ending on August 18, 2021. Available here.

Chlorocresol

The Final Screening Assessment for Chlorocresol was published. The Proposed Risk Management Approach for Chlorocresol was also published for a 60-day public comment period ending on July 21, 2021. Available here.

Talc

The proposed order adding Talc to Schedule 1 of the Canadian Environmental Protection Act, 1999 was published for a 60-day public comment period ending on July 21, 2021. Available here.

Monocyclic and Bicyclic Sesquiterpenes Group

The Draft Screening Assessment for the Monocyclic and Bicyclic Sesquiterpenes Group and the Risk Management Scope for Certain Terpenes and Terpenoids within the Monocyclic and Bicyclic Sesquiterpenes Group were published for a 60-day public comment period ending on July 7, 2021. Available Here.

Chemicals Management Plan Science Committee Reports

The meeting record for the February 2020 Chemicals Management Plan Science Committee meeting was published. A committee report on considerations for identifying potential risks from exposure to chemicals in the workplace was also published. Available Here.

Transparency in Chemicals Management

An amended version of the Approach to disclose confidential information and promote transparency in chemicals management was published to reflect the results of the pilot phase of the confidential substance identity claim review project for claims older than 10 years. Available Here.

Talc

The Final Screening Assessment for Talc (Mg3H2(SiO3)4) was published. The Risk Management Approach for Talc (Mg3H2(SiO3)4) was also published for a public comment period ending June 23, 2021. Available Here.

Thiophosphate Alkyl Esters Group

The draft screening assessment and risk management scope for the Thiophosphate Alkyl Esters Group was published for a 60-day public comment period ending on May 12, 2021. Available here

Piperazine

The Draft Screening Assessment for Piperazine was published for a 60-day public comment period ending on May 12, 2021. Available here.


Ethers Group


The Draft Screening Assessment for the Ethers Group was published for a 60-day public comment period ending on May 12, 2021. Available here.

Aliphatic Amines Group

The draft screening assessment and risk management scope for the Aliphatic Amines Group was published for a 60-day public comment period ending on May 5, 2021. Available here.